Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥2,045 JPY
Change Today -15.00 / -0.73%
Volume 1.8M
As of 2:00 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for mitsubishi tanabe pharma (4508)

Mitsubishi Tanabe Pharma Corporation uses little or no debt in its capital structure and may have less financial risk than the industry aggregate. Cash Collection is among the best in the industry and appears to be getting even better. At the end of 2015, its uncollected receivables totaled ¥130.3B JPY, which, at the current sales rate provides a Days Receivables Outstanding of 111.57. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 192.38 days.
View Balance Sheet In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
Mar 31
Mar 31
Mar 31
4 Year
Cash and Equivalents15,466.020,281.027,187.050,203.0
Short-Term Investments177,136.0215,547.0278,619.0311,563.0
TOTAL CASH AND SHORT TERM INVESTMENTS192,602.0235,828.0305,806.0361,766.0
Accounts Receivable127,166.0129,825.0123,498.0130,287.0
TOTAL RECEIVABLES127,166.0129,825.0123,498.0130,287.0
Deferred Tax Assets, Current9,343.08,373.08,153.08,319.0
Other Current Assets4,350.09,877.09,335.018,186.0
TOTAL CURRENT ASSETS419,651.0476,686.0540,492.0603,649.0
NET PROPERTY PLANT AND EQUIPMENT103,929.092,283.098,340.092,497.0
Long-Term Investments179,092.0189,473.0113,875.0115,473.0
Deferred Tax Assets, Long Term7,898.04,173.0677.0763.0
Other Intangibles3,806.04,632.036,912.035,402.0
TOTAL ASSETS819,925.0866,774.0886,476.0929,301.0
Accounts Payable28,878.038,072.033,986.034,620.0
Accrued Expenses11,121.010,291.010,169.09,957.0
Short-Term Borrowings2,170.01,174.01,225.0--
Current Portion of Long-Term Debt/Capital Lease----128.0132.0
Current Income Taxes Payable24,479.033,665.026,934.045,144.0
Other Current Liabilities, Total2,936.02,916.09,395.015,546.0
TOTAL CURRENT LIABILITIES69,584.086,118.081,837.0105,399.0
Long-Term Debt----958.0894.0
Minority Interest5,740.04,993.011,791.011,455.0
Pension & Other Post-Retirement Benefits10,590.09,451.02,146.02,456.0
Deferred Tax Liability Non-Current9,338.08,365.013,356.09,776.0
Other Non-Current Liabilities8,928.09,918.010,342.010,342.0
TOTAL LIABILITIES98,440.0113,852.0108,639.0128,867.0
Common Stock50,000.050,000.050,000.050,000.0
Additional Paid in Capital451,186.0451,186.0451,186.0451,186.0
Retained Earnings224,168.0243,621.0266,575.0275,325.0
Treasury Stock-486.0-487.0-490.0-493.0
Comprehensive Income and Other-9,123.03,609.0-1,225.012,961.0
TOTAL COMMON EQUITY715,745.0747,929.0766,046.0788,979.0
TOTAL EQUITY721,485.0752,922.0777,837.0800,434.0
TOTAL LIABILITIES AND EQUITY819,925.0866,774.0886,476.0929,301.0

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4508:JP ¥2,045.00 JPY -15.00

4508 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4508.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4508 Industry Range
Price/Earnings 26.3x
Price/Sales 2.8x
Price/Book 1.5x
Price/Cash Flow 20.5x
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MITSUBISHI TANABE PHARMA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at